Literature DB >> 32291202

The COVID-19 outbreak: From "black swan" to global challenges and opportunities.

Stefano Mazzoleni1, Giuseppe Turchetti2, Nicolino Ambrosino3.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32291202      PMCID: PMC7151362          DOI: 10.1016/j.pulmoe.2020.03.002

Source DB:  PubMed          Journal:  Pulmonology        ISSN: 2531-0429


× No keyword cloud information.
The world is in war against the pandemic of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2, the cause of COVID-19) and casualties (like in war: casualties) are increasing dramatically throughout the world. This disease may cause massive diffuse alveolar damage resulting in hypoxaemic acute respiratory failure (ARF) requiring, in a high percentage of cases, mechanical ventilation.1, 2, 3 Behaviours and lifestyles are changing all over the world due to restrictions and lockdowns imposed by national governments to contain the diffusion. This editorial is written in the middle of the war and only final and complete data will allow to draw solid conclusions. However, even with partial information the scientific community has the moral duty to raise questions and to try to provide interdisciplinary analyses and a prospective vision based on societal, clinical, economical, organisational, technological and ethical challenges which arise from this worldwide emergency. With respect to the organisation of the healthcare services, in most countries the available ICU beds seem not to be properly sized to face the dramatic requirements. In the years, many governments around the world have reduced the economic resources to their healthcare systems and the current organisation of our hospitals may not fit present needs. The huge prevalence of the disease requires the distribution of patients according to different levels of interventions from simple medical supervision to oxygen (supplementation or High Flow), to non-invasive ventilation (NIV), to intubation while preserving safety of doctors and nurses.4, 5 Do we have the infrastructure for these purposes? Furthermore, the shortage of ICU beds and the higher mortality among oldest and weakest people pose dramatic ethical questions regarding the triage of the patients with possible need of “Sophie's Choice”. Moreover, it is not only a matter of infrastructure, but also of competences. Health authorities launch appeals for more troops (doctors and nurses) and weapons (ventilators, masks and other tools). The physiology of COVID-19 induces ARF which requires high skills (e.g. to appropriately set the ventilator either for NIV or invasive ventilation). Do we have such skilled troops? Furthermore, how to equip our troops? Other than to provide the healthcare professionals with the proper safety equipment, an appropriate use of available technologies is required. Robots, Artificial Intelligence, Big Data Analytics, mobile apps and tele-medicine can be effective resources also in fighting pandemics. In fact, robots have a high potential in different infection-related applications, such as environment disinfection, medications and food delivery, assessment of clinical parameters and security checks. For disease prevention autonomous or remote-controlled robots can be deployed for noncontact ultraviolet surface disinfection. Mobile robots embedded with temperature measurement sensors (i.e., thermal sensors) and vision algorithms (for facial recognition) may lead to cost-effective, fast and effective screening of population in hospitals and public areas (airports, railway stations, ports, underground stations, etc.). Robots may also be deployed to optimise nasopharyngeal and oropharyngeal swabbing in terms of increase of the process speed and protection of healthcare professionals. Another potential area of application is represented by delivery of samples and medicines to infected persons by means of drones or autonomous ground robots. Data collected by robots and mobile apps may be analysed by means of dedicated machine learning algorithms able to extract meaningful information for infection prevention and prediction, diffusion control, and diagnosis and treatment of infected persons. Data can be transmitted to hospital information and security systems and can be matched with data collected by mobile applications to support contact tracing efforts amid the outbreak to limit the infection diffusion: however, data protection and data privacy regulations and laws must be guaranteed.13, 14 Which lessons from the middle of the storm we are still fighting against? We highlight at least three precious lessons: The expense in the healthcare field must be considered an investment and not a cost. We must build strong healthcare systems, able to work well in normal and to promptly react in extraordinary times. Let us think of the economic impact produced by the pandemic. How much of the economic losses might have been avoided by previous major investments in healthcare? What is the opportunity cost today of not having done so? We must not repeat the same mistake! Let's invest in research, innovation, technology, organisational models. In healthcare we must adopt a strategic approach. There are some answers that even in emergency conditions can be provided (mask production through the reconversion of some production activities, etc.), others not. How to make available in a few days, skills that take years to be trained? We need to redesign the academic programmes for specializations we may require most in the next years (such as respiratory medicine). We need to scan the horizon, trying to forecast – analysing trends in the population, in the behaviours, in the lifestyles, and in the society, and taking into account the potential large-scale events (although unlikely) – future scenarios. We must have a common systematic approach in the response. The international community must share ways of reacting and common protocols for managing these emergencies. A global effort is required in terms of organisation in collaborative networks, and of implementation of international emergency policies. Our countries seem unprepared: (a) absence of codified procedures and predefined plans to manage events like COVID-19 outbreak; (b) different behaviours between country and country in the way of managing the emergency. As said, we are still in the middle of the storm, more lessons will be taught from this emergency before it is over. It will only depend on us if we will be able to learn them and to turn the “black swan” into a growth opportunity for the entire international community.
  12 in total

1.  Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement.

Authors:  Nicolino Ambrosino; Michele Vitacca; Michael Dreher; Valentina Isetta; Josep M Montserrat; Thomy Tonia; Giuseppe Turchetti; Joao Carlos Winck; Felip Burgos; Michael Kampelmacher; Guido Vagheggini
Journal:  Eur Respir J       Date:  2016-07-07       Impact factor: 16.671

2.  Artificial Intelligence for infectious disease Big Data Analytics.

Authors:  Zoie S Y Wong; Jiaqi Zhou; Qingpeng Zhang
Journal:  Infect Dis Health       Date:  2018-11-02

3.  Fair Allocation of Scarce Medical Resources in the Time of Covid-19.

Authors:  Ezekiel J Emanuel; Govind Persad; Ross Upshur; Beatriz Thome; Michael Parker; Aaron Glickman; Cathy Zhang; Connor Boyle; Maxwell Smith; James P Phillips
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

Review 4.  Use of drones in clinical microbiology and infectious diseases: current status, challenges and barriers.

Authors:  M Poljak; A Šterbenc
Journal:  Clin Microbiol Infect       Date:  2019-09-28       Impact factor: 8.067

5.  Evaluation of an ultraviolet room disinfection protocol to decrease nursing home microbial burden, infection and hospitalization rates.

Authors:  Christine R Kovach; Yavuz Taneli; Tammy Neiman; Elaine M Dyer; Alvin Jason A Arzaga; Sheryl T Kelber
Journal:  BMC Infect Dis       Date:  2017-03-03       Impact factor: 3.090

6.  Identification of COVID-19 can be quicker through artificial intelligence framework using a mobile phone-based survey when cities and towns are under quarantine.

Authors:  Arni S R Srinivasa Rao; Jose A Vazquez
Journal:  Infect Control Hosp Epidemiol       Date:  2020-03-03       Impact factor: 3.254

7.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

8.  More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China.

Authors:  Lili Guan; Luqian Zhou; Jinnong Zhang; Wei Peng; Rongchang Chen
Journal:  Eur Respir J       Date:  2020-03-20       Impact factor: 16.671

9.  And now for something completely different: from 2019-nCoV and COVID-19 to 2020-nMan.

Authors:  F Froes
Journal:  Pulmonology       Date:  2020-03-06

10.  Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).

Authors:  Waleed Alhazzani; Morten Hylander Møller; Yaseen M Arabi; Mark Loeb; Michelle Ng Gong; Eddy Fan; Simon Oczkowski; Mitchell M Levy; Lennie Derde; Amy Dzierba; Bin Du; Michael Aboodi; Hannah Wunsch; Maurizio Cecconi; Younsuck Koh; Daniel S Chertow; Kathryn Maitland; Fayez Alshamsi; Emilie Belley-Cote; Massimiliano Greco; Matthew Laundy; Jill S Morgan; Jozef Kesecioglu; Allison McGeer; Leonard Mermel; Manoj J Mammen; Paul E Alexander; Amy Arrington; John E Centofanti; Giuseppe Citerio; Bandar Baw; Ziad A Memish; Naomi Hammond; Frederick G Hayden; Laura Evans; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2020-03-28       Impact factor: 17.440

View more
  6 in total

1.  Changes in the demand for CSR activities and stakeholder engagement based on research conducted among public relations specialists in Poland, with consideration of the SARS-COV-2 pandemic.

Authors:  Dariusz Tworzydło; Sławomir Gawroński; Agata Opolska-Bielańska; Mateusz Lach
Journal:  Corp Soc Responsib Environ Manag       Date:  2021-08-09

2.  Rapid transition to online teaching program during COVID-19 lockdown: Experience from a medical college of India.

Authors:  Amir Maroof Khan; Somdatta Patra; Piyush Gupta; Arun Kumar Sharma; Anil K Jain
Journal:  J Educ Health Promot       Date:  2021-03-31

3.  The impact of Covid-19 pandemic on corporate social responsibility and marketing philosophy.

Authors:  Hongwei He; Lloyd Harris
Journal:  J Bus Res       Date:  2020-05-21

Review 4.  COVID-19 pandemic and non invasive respiratory management: Every Goliath needs a David. An evidence based evaluation of problems.

Authors:  J C Winck; N Ambrosino
Journal:  Pulmonology       Date:  2020-04-27

Review 5.  Robotics in Simulated COVID-19 Patient Room for Health Care Worker Effector Tasks: Preliminary, Feasibility Experiments.

Authors:  W David Freeman; Devang K Sanghavi; Masood S Sarab; Mary S Kindred; Elizabeth M Dieck; Suzanne M Brown; Tom Szambelan; Justin Doty; Brendan Ball; Heidi M Felix; Jesse C Dove; Jorge M Mallea; Christy Soares; Leslie V Simon
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2020-12-14

Review 6.  Shaping the Future of Rare Diseases after a Global Health Emergency: Organisational Points to Consider.

Authors:  Rosaria Talarico; Diana Marinello; Sara Cannizzo; Andrea Gaglioti; Simone Ticciati; Claudio Carta; Yllka Kodra; Mojgan Azadegan; Domenica Taruscio; Marta Mosca; Giuseppe Turchetti
Journal:  Int J Environ Res Public Health       Date:  2020-11-23       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.